Epigenomics AG Profile

2.89
USD 0.11  3.96%
15%
0%

Epigenomics AG Summary

Epigenomics AG (EPGNF) is traded on OTC Market in USA. It is located in Geneststrasse 5 and employs 43 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 70.63 M. Epigenomics AG has 22.74 M outstanding shares. EPIGENOMICS AG BE has accumulated about 15 M in cash with (8.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check Epigenomics AG Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 2.89HorizonTargetOdds Above 2.89
?%30 days 2.89 ?%
Based on normal probability distribution, the odds of Epigenomics AG to move above current price in 30 days from now is about 0.0% (This Epigenomics AG probability density function shows the probability of Epigenomics AG Stock to fall within a particular range of prices over 30 days) .

Key Fundamentals

Epigenomics AG Against Markets

Current Ratings

Epigenomics AG 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for Epigenomics AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Epigenomics AG, a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic tests for the screening, early detection, and diagnosis of cancer in Germany and internationally. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics AG is traded on OTC Market in USA. more
NameEpigenomics AG
CEOGregory HamiltonView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressGeneststrasse 5
ExchangeOTC Market
BenchmarkDOW
Websitewww.epigenomics.com
Contact Number49 30 243 450
CurrencyUSD - US Dollar

Diversify with Epigenomics AG

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Epigenomics AG to your portfolio

Management

Epigenomics AG Corporate Management
Antje Zeise Manager Investor Relations
Guenther Reiter Member of the Supervisory Board
Ann Kessler Member of the Supervisory Board
Helge Lubenow Member of the Supervisory Board, Ph.D
Additionally see Investing Opportunities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.